• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测轻度认知障碍向阿尔茨海默病进展的脂质组学标志物。

Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer's disease.

机构信息

Department of Epidemiology and Biostatistics, Clinical Big Data Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.

Center for Clinical Medical Humanities, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.

出版信息

FASEB J. 2023 Jul;37(7):e22998. doi: 10.1096/fj.202201584RR.

DOI:10.1096/fj.202201584RR
PMID:37289136
Abstract

Dementia is a well-known syndrome and Alzheimer's disease (AD) is the main cause of dementia. Lipids play a key role in the pathogenesis of AD, however, the prediction value of serum lipidomics on AD remains unclear. This study aims to construct a lipid score system to predict the risk of progression from mild cognitive impairment (MCI) to AD. First, we used the least absolute shrinkage and selection operator (LASSO) Cox regression model to select the lipids that can signify the progression from MCI to AD based on 310 older adults with MCI. Then we constructed a lipid score based on 14 single lipids using Cox regression and estimated the association between the lipid score and progression from MCI to AD. The prevalence of AD in the low-, intermediate- and high-score groups was 42.3%, 59.8%, and 79.8%, respectively. The participants in the intermediate- and high-score group had a 1.65-fold (95% CI 1.10 to 2.47) and 3.55-fold (95% CI 2.40 to 5.26) higher risk of AD, respectively, as compared to those with low lipid scores. The lipid score showed moderate prediction efficacy (c-statistics > 0.72). These results suggested that the score system based on serum lipidomics is useful for the prediction of progression from MCI to AD.

摘要

痴呆是一种众所周知的综合征,阿尔茨海默病(AD)是痴呆的主要病因。脂质在 AD 的发病机制中起着关键作用,然而,血清脂质组学对 AD 的预测价值尚不清楚。本研究旨在构建一个脂质评分系统,以预测从轻度认知障碍(MCI)到 AD 的进展风险。首先,我们使用最小绝对收缩和选择算子(LASSO)Cox 回归模型,基于 310 名 MCI 老年人,选择能够表明从 MCI 进展为 AD 的脂质。然后,我们使用 Cox 回归基于 14 种单脂质构建了一个脂质评分,并估计了脂质评分与从 MCI 进展为 AD 之间的关联。低、中、高分组中 AD 的患病率分别为 42.3%、59.8%和 79.8%。与低脂质评分者相比,中高分组的 AD 风险分别增加了 1.65 倍(95%CI 1.10 至 2.47)和 3.55 倍(95%CI 2.40 至 5.26)。脂质评分显示出中等的预测效能(c 统计值>0.72)。这些结果表明,基于血清脂质组学的评分系统可用于预测从 MCI 到 AD 的进展。

相似文献

1
Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer's disease.用于预测轻度认知障碍向阿尔茨海默病进展的脂质组学标志物。
FASEB J. 2023 Jul;37(7):e22998. doi: 10.1096/fj.202201584RR.
2
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.两种言语记忆测量方法联合应用对阿尔茨海默病所致轻度认知障碍的诊断及预后价值
J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.
3
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.血清磷脂酰乙醇胺和溶血磷脂酰乙醇胺水平可区分阿尔茨海默病与对照,并预测从轻度认知障碍进展。
J Alzheimers Dis. 2021;80(1):311-319. doi: 10.3233/JAD-201420.
4
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.在阿尔茨海默病患者中,与从轻度认知障碍向痴呆快速进展相关的是损伤标志物,而不是淀粉样蛋白标志物。
J Alzheimers Dis. 2012;29(2):319-27. doi: 10.3233/JAD-2011-111694.
5
Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.《 Mayo 诊所老龄化研究中的轻度认知障碍脂质组学网络》
J Alzheimers Dis. 2021;81(2):533-543. doi: 10.3233/JAD-201347.
6
Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对轻度认知障碍向阿尔茨海默病转化的预测价值增加。
Transl Neurodegener. 2020 Aug 3;9(1):30. doi: 10.1186/s40035-020-00210-5.
7
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.埃尔朗根评分作为预测阿尔茨海默病轻度认知障碍向痴呆进展的工具。
Alzheimers Res Ther. 2019 Jan 5;11(1):2. doi: 10.1186/s13195-018-0456-x.
8
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.阿尔茨海默病全基因组显著风险因素:在轻度认知障碍患者进展为阿尔茨海默病所致痴呆中的作用。
Mol Psychiatry. 2017 Jan;22(1):153-160. doi: 10.1038/mp.2016.18. Epub 2016 Mar 15.
9
Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.脑脊液脂质组学在阿尔茨海默病生物标志物中的研究。
Mol Omics. 2021 Jun 14;17(3):454-463. doi: 10.1039/d0mo00186d.
10
Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.在一个对老年人进行了12年随访的基于人群的队列中,验证澳大利亚国立大学阿尔茨海默病风险指数(ANU-ADRI)和遗传风险评分在进展为认知障碍中的作用。
Alzheimers Res Ther. 2017 Mar 4;9(1):16. doi: 10.1186/s13195-017-0240-3.

引用本文的文献

1
Regulation of synaptic function and lipid metabolism.突触功能与脂质代谢的调节。
Neural Regen Res. 2026 Mar 1;21(3):1037-1057. doi: 10.4103/NRR.NRR-D-24-01412. Epub 2025 Apr 29.
2
Plasma lipidomics in early APP/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?早期 APP/PS1 雌性小鼠模型中的血浆脂质组学及其与大脑的关系:是否受动情周期影响?
Alzheimers Res Ther. 2024 Aug 14;16(1):183. doi: 10.1186/s13195-024-01549-x.
3
Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with and mild cognitive impairment.
大脑和血清脂质组学特征表明兰兹循环酰基链重塑与轻度认知障碍有关。
Front Aging Neurosci. 2024 Jun 11;16:1419253. doi: 10.3389/fnagi.2024.1419253. eCollection 2024.
4
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.脑胆固醇与阿尔茨海默病:探针和药物研发中的挑战与机遇。
Brain. 2024 May 3;147(5):1622-1635. doi: 10.1093/brain/awae028.